VARIVAX Varicella Virus Vaccine Live 1350 [PFU]/.5mL Injection, Powder, Lyophilized, For Suspension, 1 vial — NDC 0006-4826-00 (Billing 00006-4826-00)
This is a package of 1 vial of VARIVAX Varicella Virus Vaccine Live 1350 [PFU]/.5mL Injection, Powder, Lyophilized, For Suspension from Merck Sharp & Dohme LLC, no longer marketed, no longer in the FDA NDC Directory. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 0006-4826-00 alone.
- Record
- FDA NDC Directory package listing · Vaccine
- Code segments
- 0006 labeler · 4826 product · 00 package
- Billing quantity
- 1 EA per package
- Barcode (UPC-A, from the NDC)
- 3 0006482600 5
- FDA record last changed
- Jul 14, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 060760
- GCN: 26999
- HICL (First Databank): 033642
- AHFS class code: 80:12.00.00
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
Why get vaccinated? Varicella vaccine may prevent chickenpox that may occur from an infection with varicella-zoster virus. Infection with varicella-zoster virus can cause the following: headache, fever, tiredness, achiness, and an itchy, blistering rash. The rash may cause the skin to be infected. Serious effects that may be life-threatening include pneumonia, brain inflammation, and Reye syndrome (a condition that affects the liver and the brain.) Varicella vaccine contains live virus that has been weakened so it does not cause disease but can still stimulate the body to make antibodies agai...
Read the full MedlinePlus article ↗Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 7, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 00006-4826-00 You're viewing this Main listing | 1 VIAL, SINGLE-DOSE in 1 CARTON / .5 mL in 1 VIAL, SINGLE-DOSE | 1995-03-17 | — | Discontinued by firm |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Varivax 1350 [PFU]/.5mLthis 00006-4826-00 | Merck | 1 vial | — | — | Discontinued | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Purple Book · refreshed Oct 5, 2026
- CMS NADAC weekly file
Availability & biosimilar status
Biologics have no small-molecule generics; biosimilar competition is tracked in the FDA Purple Book.
Where does this data come from?
- FDA Purple Book · refreshed Oct 5, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Oct 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 27432CM55Q
Bovine albumin is a natural protein derived from cow blood. In medicines, it acts as a stabilizer and binder, helping preserve active ingredients and hold solid formulations together.
-
UNII 9G34HU7RV0
EDTA is a chemical compound that binds to metals and other substances in medicines. It's used as a preservative and stabilizer to prevent discoloration and extend shelf life.
-
12.5 mg / 0.5 mL
UNII 2G86QN327L
Gelatin is a protein derived from animal collagen, commonly used in medicines as a gelling agent and capsule material. It helps create soft or hard capsule shells that hold and release medication, and can also thicken liquid formulations.
-
0.5 mg / 0.5 mL
UNII W81N5U6R6U
Sodium glutamate is a salt form of glutamic acid, a naturally occurring amino acid. It serves as a flavor enhancer and pH buffer in medications, helping to improve taste and maintain chemical stability.
-
UNII I16QD7X297
Neomycin is an antibiotic substance. In topical medicines, it serves as an active antimicrobial agent rather than an inactive excipient, helping prevent bacterial infection in wounds or skin conditions.
-
0.08 mg / 0.5 mL
UNII 660YQ98I10
Potassium chloride is a mineral salt used in medicines as a buffer and to help maintain the proper pH balance and stability of the formulation during storage and use.
-
0.08 mg / 0.5 mL
UNII 4J9FJ0HL51
Potassium phosphate, monobasic is a salt compound used in medicines as a pH buffer and electrolyte source. It helps stabilize the acidity level of liquid and powdered formulations.
-
3.2 mg / 0.5 mL
UNII 451W47IQ8X
Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
-
0.45 mg / 0.5 mL
UNII GR686LBA74
Sodium phosphate, dibasic is a salt derived from phosphoric acid. It acts as a buffer to help maintain the medicine's pH balance and may serve as a binder or filler in tablets and capsules.
-
UNII 3980JIH2SW
A salt form of phosphoric acid that acts as a buffer and pH adjuster in medicines. It helps keep the product at the correct acidity level for stability and effectiveness.
-
25 mg / 0.5 mL
UNII C151H8M554
A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
11 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 6, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Merck Sharp & Dohme LLC labeler code 00006
- ERVEBO ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN 72000000 [PFU]/mL Injection, Solution NDC 0006-4293-02
- STERILE DILUENT Sterile Water .7 mL/.7mL Injection NDC 0006-4309-00
- VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 2 ug/.5mL; 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 2 ug/.5mL; 4 C Injection, Suspension NDC 0006-4329-02
- CAPVAXIVE Pneumococcal 21-valent Conjugate Vaccine 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 4 ug/.5mL; 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN 4 ug/.5mL; 7F Injection, Solution NDC 0006-4347-01
- RotaTeq Rotavirus Vaccine, Live, Oral, Pentavalent 2200000 [iU]/2mL; 2800000 [iU]/2mL; 2200000 [iU]/2mL Solution NDC 0006-4379-02
- M-M-R II measles, mumps, and rubella virus vaccine live 1000 [TCID_50]/.5mL; 12500 [TCID_50]/.5mL; 27/3 LIVE ANTIGEN 1000 [TCID_50]/.5mL Injection, Powder, Lyophilized, For Suspension NDC 0006-4681-00
- VARIVAX Varicella Virus Vaccine Live 1350 [PFU]/.5mL Injection, Powder, Lyophilized, For Suspension NDC 0006-4827-00
- VAQTA hepatitis A vaccine, inactivated 326F ANTIGEN (FORMALDEHYDE INACTIVATED) 25 [iU]/.5mL Injection, Suspension NDC 0006-4831-41
- PNEUMOVAX 23 pneumococcal vaccine polyvalent 1 CAPSULAR POLYSACCHARIDE ANTIGEN 25 ug/.5mL; 2 CAPSULAR POLYSACCHARIDE ANTIGEN 25 ug/.5mL; 3 CAPSULAR POLYSACCHARIDE ANTIGEN 25 ug/.5mL Injection, Solution NDC 0006-4837-03
- VAQTA hepatitis A vaccine, inactivated 326F ANTIGEN (FORMALDEHYDE INACTIVATED) 50 [iU]/mL Injection, Suspension NDC 0006-4841-00
- PedvaxHIB Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) 7.5 ug/.5mL Injection, Suspension NDC 0006-4897-00
- PNEUMOVAX 23 pneumococcal vaccine polyvalent 1 CAPSULAR POLYSACCHARIDE ANTIGEN 25 ug/.5mL; 2 CAPSULAR POLYSACCHARIDE ANTIGEN 25 ug/.5mL; 3 CAPSULAR POLYSACCHARIDE ANTIGEN 25 ug/.5mL Injection, Solution NDC 0006-4943-00
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |